Purpose: To evaluate the usefulness of intravenous patient-controlled
analgesia (PCA) fentanyl for labour analgesia, its effectiveness for m
aternal pain and safely for the fetus ana newborn. Methods: Twenty pri
migravidas were randomised to receive intravenous PCA fentanyl or epid
ural analgesia for labour pain. Maternal pain, heart rate and arterial
oxyhaemoglobin saturation (SpO(2)) were monitored, Fetal and neonatal
monitoring included cardiotocogram (CTG), APGAR, neurological scoring
and static-charge-sensitive bed (SCSB) recording for 12 hr postnatall
y with ECG and SpO(2). Fentanyl concentrations and pH of umbilical art
ery and vein were analysed. Results: initially, epidural analgesia was
more effective (P = 0.01), and three patients in the fentanyl group w
ere given epidural due to unsatisfactory pain relief. Overall satisfac
tion for analgesia did not differ between the groups. Maternal side-ef
fects were more frequent in the fentanyl group (dizziness and tirednes
s most often, P = 0.0001). Severe side-effects were not reported. in C
TG there were no differences between groups. Aii the newborns were hea
lthy, APC;AR and pH were normal. Naloxone was not used, Neurological s
coring was similar in both groups, In 12 hr monitoring heart rate, bre
athing frequency and movement time were similar in both groups, but Sp
O(2) was lower in the fentanyl group (P < 0.001). Umbilical cord fenta
nyl concentrations were low or beyond the detection limit. Conclusion:
intravenous fentanyl can be used for labour analgesia with the doses
reported here as an alternative to epidural analgesia. However, the fe
tus and neonate must be appropriately monitored. Naloxone and oxygen s
hould be available ii neonatal distress occurs.